MARKET

PACB

PACB

Pacific Biosc
NASDAQ
1.470
-0.100
-6.37%
After Hours: 1.480 +0.01 +0.68% 19:58 06/21 EDT
OPEN
1.570
PREV CLOSE
1.570
HIGH
1.610
LOW
1.460
VOLUME
10.71M
TURNOVER
0
52 WEEK HIGH
14.55
52 WEEK LOW
1.250
MARKET CAP
400.36M
P/E (TTM)
-1.2913
1D
5D
1M
3M
1Y
5Y
Pacific Biosciences Shareholders Shape Company’s Strategic Future
TipRanks · 1d ago
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know
NASDAQ · 3d ago
Weekly Report: what happened at PACB last week (0610-0614)?
Weekly Report · 5d ago
PacBio And CoLoRS Releases HiFi Long-Read Variant Database
Benzinga · 06/10 13:09
Weekly Report: what happened at PACB last week (0603-0607)?
Weekly Report · 06/10 09:27
We Think Pacific Biosciences of California (NASDAQ:PACB) Has A Fair Chunk Of Debt
Pacific Biosciences of California, Inc. (NASDAQ:PACB) makes use of debt. The company has US$892.5m in debt, but also has $561.9m in cash. It burned through US$249m of cash in the last year. Pacific Bioscience of California's debt levels suggest the company is very risky. The future profitability of the company will decide if the company can strengthen its debt.
Simply Wall St · 06/08 14:57
Jefferies Initiates Coverage of Pacific Biosciences of California (PACB) with Buy Recommendation
NASDAQ · 06/04 02:54
Critical Insights From Pacific Biosciences Analyst Ratings: What You Need To Know
Pacific Biosciences (NASDAQ:PACB) is a biotechnology company. 11 analysts have published ratings on the company in the last three months. The company has an average 12-month price target of $3.64. Analysts have set a decline of 57.92% from the prior average price target for the company.
Benzinga · 06/03 19:00
More
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

Webull offers Pacific Biosciences of California Inc stock information, including NASDAQ: PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PACB stock methods without spending real money on the virtual paper trading platform.